PTGS2 and colorectal cancer: Since, COX-2 was first demonstrated to be increased in colorectal cancer by Eberhart et al., (1994) and thereafter, numerous studies have shown inconstant expression levels of COX-2 in colorectal cancer (Soumaoro et al., 2004; Yamauchi et al., 2002; Xiong et al., 2005).